Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.22.2.2
Stockholders' Equity (Details)
 9 Months Ended
Aug. 31, 2022
shares
Sep. 17, 2021
USD ($)
$ / shares
tranche
shares
Sep. 30, 2022
USD ($)
shares
Sep. 30, 2021
USD ($)
Dec. 31, 2021
shares
Aug. 19, 2021
shares
Jan. 07, 2021
shares
Jan. 06, 2021
shares
Class of Warrant or Right [Line Items]                
Referral agreement term   5 years            
Class of warrant or right, granted in period (in shares)   300,000            
Exercise price of warrant (in usd per share) | $ / shares   $ 0.72            
Number of tranches | tranche   2            
Warrants outstanding | $   $ 149,551            
Warrants outstanding, term   7 years            
Shares vested (in shares) 85,862              
Stock warrant expense | $     $ 28,477 $ 0        
Common stock shares authorized (in shares)     200,000,000   200,000,000 200,000,000 150,000,000 100,000,000
Measurement Input, Implied Volatility                
Class of Warrant or Right [Line Items]                
Warrants outstanding, measurement input   1            
Measurement Input, Share Price                
Class of Warrant or Right [Line Items]                
Warrants outstanding, measurement input | $ / shares   0.71            
Measurement Input, Risk-free Yield                
Class of Warrant or Right [Line Items]                
Warrants outstanding, measurement input   0.0117            
Maximum                
Class of Warrant or Right [Line Items]                
Referral agreement term   5 years